[1]
W. Arozal, K. Watanabe, P. T. Veeraveedu, M. Ma, and N. Nafrialdi, “Telmisartan inhibits the progression of cardiomyopathy in daunorubicin treated rats: the role of advanced glycation end products”, Med J Indones, vol. 20, no. 4, pp. 255–62, Nov. 2011.